em para o uso em estrabismo, blefaroespasmo e espasmo hemifacial. . Assim, sintomas inespecíficos, como cefaléia ou reação infecciosa, podem ter. El blefaroespasmo, la segunda distonía focal más común, es el cierre involuntario y También llamada disfonía espástica o distonía de la laringe, causa. La Blefaritis es una patología que afecta a los párpados y causa inflamación en el borde de los .. Temblores en los párpados: mioquimia y blefaroespasmo.
|Published (Last):||11 April 2004|
|PDF File Size:||4.94 Mb|
|ePub File Size:||12.32 Mb|
|Price:||Free* [*Free Regsitration Required]|
Adverse effects associated with facial application of botulinum toxin: To estimate the occurrence of adverse effects associated with the use of botulinum toxin by performing a systematic review blefaroespxsmo meta-analysis. The occurrence of the adverse effects was estimated of the dell frequency for case report and bletaroespasmo the relative risk for randomized trials.
Heterogeneity was evaluated with the Q test and I 2 index. Egger’s significance test was used to identify the publication bias. Sensitivity analysis was performed to evaluate the effect of the publication biases. Eight randomized trials and thirteen case reports filled the inclusion criteria. In the systematic review of case reports, 1, subjects were studied and Eyelid ptosis was the most frequent adverse effect, presenting in 34 3.
In the meta-analysis of randomized trials, the overall relative risk for adverse effects as headache, eyelid ptosis, local reaction and infection blefwroespasmo respectively: For all comparisons, P values were greater than 0. Ptosis was the most frequent adverse effect and showed the higher relative risk associated with botulinum toxin.
It is necessary to perform a pattern of adverse effects related for better understanding the relationship between adverse effects and use of botulinum toxin. Um total de 1.
Efeitos adversos – estudos randomizados. De um total de 1. Contraindications and complications with the use of botulinum toxin. Complications and adverse reactions with the use of botulinum toxin.
Botulinum toxin in ophthalmology. Review blefaroes;asmo the use of botulinum toxin for hyperhidrosis and cosmetic purposes. Botulinum toxin type A injections: J Am Acad Dermatol. Pogue J, Yusuf S. Overcoming the limitations of current meta-analysis of randomised controlled trials. Cochrane Handbook for Systematic Reviews of Interventions. Efficacy of different intraocular lens materials and optic edge designs in blefarpespasmo posterior capsular opacification: Cochrane eyes and Vision Group.
Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Quantifying heterogeneity in a meta-analysis. Bias in meta-analysis detected by a simple, graphical test. Botulinum toxin A for the treatment of facial hyperkinetic wrinkle lines in Koreans. A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type A in the treatment of lateral orbital rhytides.
A prospective, double-blind, randomized, parallel- group, dose-ranging study of botulinum toxin type a in female subjects with horizontal forehead rhytides.
Botulinum toxin A treatment for primary hemifacial spasm: Botulinum-A toxin treatment of the lower eyelid improves csusas rhytides and widens the eye. Quantification of the efficacy of botulinum toxin type A by digital image analysis.
Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application. Niamtu J 3 rd. J Oral Maxillofac Surg.
Cómo Mejorar los Tics del Párpado
Local injection of botulinum toxin type A for hemifacial spasm. Neurol Med Chir Tokyo. Botulinum a toxin treatment of hemifacial spasm and blepharospasm.
J Korean Med Sci.
Enfermedades y problemas oculares | Institut Català de Retina
Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection. Arch Otolaryngol Head Neck Surg. Blefarospasmo essencial e espasmo hemifacial: Effect of botulinum toxin type A on movement-associated rhytides following CO2 laser resurfacing.
Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines.
Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow’s feet. Efficacy and safety of 3- and 5-injection patterns 30 and 50 U of botulinum toxin A Dysport for the treatment of wrinkles in the glabella and the central forehead region. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.
A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: Carruthers J, Carruthers A.
Botulinum toxin type A treatment of multiple upper facial sites: A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: Meta-analysis and adverse drug reactions. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Dry eyes and superficial punctate keratitis: All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Drl License.
Services on Demand Journal. Rua Casa do Ator, – cj. How to cite this article.